ASTRAZENECA TO STREAMLINE US SALES ORGANISATION
AstraZeneca announced today that it will reduce its US sales force by approximately 1,150 leadership positions and sales representatives as part of the company’s ongoing strategy to operate its business more efficiently to best serve patients in the US.
These changes, which were not included in previously announced efficiencies to the US business, will account for roughly 24 per cent of the co